RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+9.05%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$661M
AUM Growth
+$661M
(+5.4%)
Cap. Flow
-$9.85M
Cap. Flow
% of AUM
-1.49%
Top 10 Holdings %
Top 10 Hldgs %
25.72%
Holding
101
New
10
Increased
24
Reduced
44
Closed
5
Top Buys
| 1 |
ABMD
Abiomed Inc
ABMD
|
$13M |
| 2 |
Perrigo
PRGO
|
$11.6M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$11.2M |
| 4 |
CVS Health
CVS
|
$8.12M |
| 5 |
Bausch Health
BHC
|
$7.01M |
Top Sells
| 1 |
Amgen
AMGN
|
$8.6M |
| 2 |
Alkermes
ALKS
|
$7.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$6.17M |
| 4 |
HCA Healthcare
HCA
|
$5.68M |
| 5 |
Merck
MRK
|
$4.94M |
Sector Composition
| 1 | Healthcare | 92.69% |
| 2 | Financials | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Perrigo
PRGO
$3.27B
| $21M | 3.17% | 145,000 +80,000 | +123% | +$11.6M |
|
|
ABMD
2
DELISTED
Abiomed Inc
ABMD
| $19.9M | 3% | 220,000 +144,000 | +189% | +$13M |
|
3
Medtronic
MDT
$119B
| $19.2M | 2.9% | 249,000 -16,000 | -6% | -$1.23M |
|
|
ALXN
4
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $19.1M | 2.88% | 100,000 -15,000 | -13% | -$2.86M |
|
|
5
CVS Health
CVS
$92.8B
| $17.6M | 2.66% | 180,000 +83,000 | +86% | +$8.12M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $17.2M | 2.6% | 55,000 +9,000 | +20% | +$2.81M |
|
7
AbbVie
ABBV
$372B
| $14.6M | 2.2% | 246,000 +36,000 | +17% | +$2.13M |
|
8
UnitedHealth
UNH
$281B
| $14.2M | 2.15% | 121,000 -26,000 | -18% | -$3.06M |
|
9
Pfizer
PFE
$141B
| $14.1M | 2.14% | 438,000 +17,000 | +4% | +$549K |
|
|
10
Amgen
AMGN
$155B
| $13.3M | 2.01% | 82,000 -53,000 | -39% | -$8.6M |
|
11
Cigna
CI
$80.3B
| $12.7M | 1.92% | 87,000 -18,900 | -18% | -$2.77M |
|
12
Bristol-Myers Squibb
BMY
$96B
| $12.6M | 1.9% | 183,000 -9,000 | -5% | -$619K |
|
13
Gilead Sciences
GILD
$140B
| $12.5M | 1.9% | 124,000 +9,000 | +8% | +$911K |
|
|
14
Alkermes
ALKS
$4.78B
| $12.5M | 1.9% | 158,000 -97,000 | -38% | -$7.7M |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $12.5M | 1.88% | 104,000 -32,000 | -24% | -$3.83M |
|
16
BioMarin Pharmaceuticals
BMRN
$11.2B
| $12.4M | 1.87% | 118,000 +32,000 | +37% | +$3.35M |
|
17
Eli Lilly
LLY
$657B
| $12.3M | 1.86% | 146,000 -39,000 | -21% | -$3.29M |
|
18
Elevance Health
ELV
$71.8B
| $12.3M | 1.86% | 88,000 -19,000 | -18% | -$2.65M |
|
19
Incyte
INCY
$16.5B
| $11.9M | 1.8% | 110,000 +1,000 | +0.9% | +$108K |
|
20
McKesson
MCK
$85.4B
| $11.6M | 1.76% | 59,000 -18,000 | -23% | -$3.55M |
|
21
Regeneron Pharmaceuticals
REGN
$61.5B
| $11.4M | 1.72% | 21,000 +4,500 | +27% | +$2.44M |
|
|
AET
22
DELISTED
Aetna Inc
AET
| $11.2M | 1.7% | 104,000 -34,000 | -25% | -$3.68M |
|
|
WBA
23
DELISTED
Walgreens Boots Alliance
WBA
| $11.2M | 1.7% | +132,000 | New | +$11.2M |
|
24
Zimmer Biomet
ZBH
$21B
| $11M | 1.66% | 107,000 +37,000 | +53% | +$3.8M |
|
25
Humana
HUM
$36.5B
| $10.9M | 1.65% | 61,000 -19,000 | -24% | -$3.39M |
|